Vivanza Biosciences shareholders and shareholding pattern
BSE: 530057Pharmaceuticals & BiotechnologySmall Cap
Last close ₹1.60₹0.00 (0.00%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹1.60.
52-week range of traded prices to 23 Oct 2026
₹1.41Low, 19 Oct 2026₹2.72High, 17 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹6.40 Cr4,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 7 Aug 2026
- 14.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 Jul 2026
- 1.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- 10.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 Jul 2026
- 2.34
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,075
Who owns Vivanza Biosciences, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters20.02%
- Indian institutionsNone
- Individuals and others79.98%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 21 Jan | Mar 2017Filed 6 Dec | Jun 2017Filed 20 Jul | Sep 2017Filed 18 Oct | Dec 2017Filed 20 Jan | Mar 2018Filed 21 Apr | Jun 2018Filed 21 Jul | Sep 2018Filed 20 Oct | Dec 2018Filed 19 Jan | Mar 2019Filed 20 Apr | Jun 2019Filed 22 Jul | Sep 2019Filed 16 Oct | Dec 2019Filed 11 Jan | Mar 2020Filed 14 May | Jun 2020Filed 21 Jul | Sep 2020Filed 15 Oct | Dec 2020Filed 22 Jan | Mar 2021Filed 20 Apr | Jun 2021Filed 22 Jul | Sep 2021Filed 21 Oct | Dec 2021Filed 21 Jan | Mar 2022Filed 21 Apr | Jun 2022Filed 11 Jul | Sep 2022Filed 1 Nov | Dec 2022Filed 19 Jan | Mar 2023Filed 14 Apr | Jun 2023Filed 19 Jul | Sep 2023Filed 17 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 15 Apr | Jun 2024Filed 18 Jul | Sep 2024Filed 16 Oct | Dec 2024Filed 16 Jan | Mar 2025Filed 15 Apr | Jun 2025Filed 17 Jul | Sep 2025Filed 15 Oct | Dec 2025Filed 20 Jan | Mar 2026Filed 14 Apr | Jun 2026Filed 21 Aug | Sep 2026Filed 7 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 74.98% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.29% | 44.90% | 43.24% | 40.05% | 39.86% | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% | |
| Indian promoters | 74.98% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.80% | 47.29% | 44.90% | 43.24% | 40.05% | 39.86% | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% | 20.02% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 25.02% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.20% | 52.71% | 55.10% | 56.76% | 59.95% | 60.14% | 79.98% | 79.98% | 79.98% | 79.98% | 79.98% | 79.98% | 79.98% | 79.98% |
| Shares in issue | 25,50,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 40,00,000 | 4,00,00,000what Shares in issue, Mar 2023, includes. Split on 24 Mar 2023: each share became 10. Earlier filings count the shares before it. | 4,00,00,000 | 4,00,00,000 | 4,00,00,000 | 4,00,00,000 | 4,00,00,000 | 4,00,00,000 | 4,00,00,000 | 4,00,00,000 | 4,00,00,000 | 4,00,00,000 | 4,00,00,000 | 4,00,00,000 | 4,00,00,000 | 4,00,00,000 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 23,62,000 | 38,12,000 | 38,12,000 | 22,50,000 | 22,50,000 | 22,50,000 | 8,00,000 | 8,00,000 | 8,00,000 | 8,00,000 | 8,00,000 | 35 | 35 | – | – | – | – | – | – | – | – | – | 28,62,310 | 19,12,000 | 28,62,310 | 2,86,23,100 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Promoters' shares locked in | 19,12,000 | 19,12,000 | 19,12,000 | 8,00,000 | 8,00,000 | 8,00,000 | 8,00,000 | 8,00,000 | 8,00,000 | 8,00,000 | 8,00,000 | 0 | 0 | – | – | – | – | – | – | – | – | – | 19,12,000 | 19,12,000 | 19,12,000 | 1,91,20,000 | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Vivanza Biosciences promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is PARTH HEMANT PARIKH, 19.77%.Promoter buying and selling
| Holder | ||
|---|---|---|
| PARTH HEMANT PARIKHIndividuals and Hindu undivided families | 19.77% | 79,07,622 |
| HEMANT AMRISH PARIKHIndividuals and Hindu undivided families | 0.25% | 1,00,211 |
No promoter shares are reported as pledged.
Largest public holders of Vivanza Biosciences, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 21 Jan | Mar 2017Filed 6 Dec | Jun 2017Filed 20 Jul | Sep 2017Filed 18 Oct | Dec 2017Filed 20 Jan | Mar 2018Filed 21 Apr | Jun 2018Filed 21 Jul | Sep 2018Filed 20 Oct | Dec 2018Filed 19 Jan | Mar 2019Filed 20 Apr | Jun 2019Filed 22 Jul | Sep 2019Filed 16 Oct | Dec 2019Filed 11 Jan | Mar 2020Filed 14 May | Jun 2020Filed 21 Jul | Sep 2020Filed 15 Oct | Dec 2020Filed 22 Jan | Mar 2021Filed 20 Apr | Jun 2021Filed 22 Jul | Sep 2021Filed 21 Oct | Dec 2021Filed 21 Jan | Mar 2022Filed 21 Apr | Jun 2022Filed 11 Jul | Sep 2022Filed 1 Nov | Dec 2022Filed 19 Jan | Mar 2023Filed 14 Apr | Jun 2023Filed 19 Jul | Sep 2023Filed 17 Oct | Dec 2023Filed 19 Jan | Mar 2024Filed 15 Apr | Jun 2024Filed 18 Jul | Sep 2024Filed 16 Oct | Dec 2024Filed 16 Jan | Mar 2025Filed 15 Apr | Jun 2025Filed 17 Jul | Sep 2025Filed 15 Oct | Dec 2025Filed 20 Jan | Mar 2026Filed 14 Apr | Jun 2026Filed 21 Aug | Sep 2026Filed 7 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RAVINDER SINGHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.03% | 1.50% | 1.70% | 1.75% |
| PRASHANT TYAGIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.51% | 1.51% | 1.51% | 1.51% | 1.51% | 1.51% | 1.51% |
| MANU NARANGResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.00% | 1.25% | 1.31% | 1.44% | 1.43% |
| ASHOKA METCAST LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 22.61% | 22.61% | 22.61% | 22.61% | 22.61% | 22.61% | 22.54% | 21.93% | 19.37% | 14.08% | 7.75% | 3.85% | 3.85% | 3.85% | 3.85% | 3.85% | 3.85% | – | – |
| AMMISHI M DESAIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.50% | 1.39% | – | – | – | – | – | – |
| VISHAL CHINUBHAI SUTHAR HUF(HUF)Other non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.85% | – | – | – | – | – | – | – |
| SWATI VISHAL SUTHARResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.53% | – | – | – | – | – | – | – |
| KALPESH VITHALDAS RAMIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.06% | – | – | – | – | – | – | – |
| ARDENT VENTURES LLPOther non-institutions | – | – | – | – | – | – | – | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.76% | 23.76% | 23.76% | 23.76% | 23.76% | 23.76% | 23.76% | 23.76% | 23.76% | 23.76% | 23.76% | 23.09% | – | – | – | – | – | – | – | – | – | – |
| TANYA ESTATES PRIVATE LIMITEDOther non-institutions | 8.82% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.38% | 21.73% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| ARDENT VENTURES PRIVATE LIMITEDOther non-institutions | 8.82% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | 23.75% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.